Investing

Top Analyst Upgrades and Downgrades: AK Steel, Bloom Energy, Chipotle, CIT, Cushman & Wakefield, Foot Locker, Sonos, US Steel and More

Foot Locker Inc. (NYSE: FL) was reiterated as Outperform with a $63 target price (versus a $48.32 close) at Wedbush. The firm thinks accumulating shares is the right move after the shares pulled back despite the company’s overall positive results.

Hibbett Sports Inc. (NASDAQ: HIBB) was down 30% at $20.52 on Friday after poor earnings, in a 52-week range of $11.05 to $29.60. Canaccord Genuity downgraded it to Hold from Buy and cut the price target to $21 from $31.

Kala Pharmaceuticals Inc. (NASDAQ: KALA) was reiterated as Outperform with a $51 price target (versus a $12.83 close) at Wedbush after the FDA approved its Inveltys for post-surgery eye pain. The firm did still note that it expects a financing event in 2018 or 2019 to raise additional capital to fund the company beyond its launch and beyond the 12-months of capital it currently has.

Limelight Networks Inc. (NASDAQ: LLNW) was started with a Buy rating and a $6 price target (versus a $4.38 close) at Craig-Hallum. The 52-week trading range is $3.46 to $6.05, and the consensus target price was $6.30.

Paratek Pharmaceuticals Inc. (NASDAQ: PRTK) was started as Neutral and assigned a $13 price objective (versus a $10.30 close) at Merrill Lynch.

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) was started with a Buy rating and assigned an $8.50 price target (versus a $2.81 close) at Citigroup. The stock was indicated up 10% at $3.10 on the call, in a 52-week range of $2.28 to $4.71.

Sierra Oncology Inc. (NASDAQ: SRRA) was reiterated as Outperform with a $6 price target (versus a $1.78 close) at Wedbush. The firm sees the acquisition of momelotinib as an attractive opportunity to develop a well-understood Phase 3 asset with clear utility in a setting with unmet need, and it also called the recent sell-off in shares an attractive buying opportunity.

Sonos Inc. (NASDAQ: SONO) has seen its quiet period come to an end, and shares were down almost 3% at $20.21 on Friday. Stifel started it as Hold with a $20 price target, and Morgan Stanley started coverage as Equal Weight and also with a $20 target. Jefferies also started Sonos as Hold, but with a $23 price target. Raymond James started it as Outperform, but no price target information was seen. Goldman Sachs started it as Buy and assigned a $25 target price.

Steel Dynamics Inc. (NASDAQ: STLD) was raised to Overweight from Equal Weight and the price target was raised to $52 from $50 (versus a $44.75 close) at Morgan Stanley. Steel Dynamics shares were indicated up over 2% at $45.80 on Monday.

United States Steel Corp. (NYSE: X) saw a two-notch downgraded to Underweight from Overweight with a $30 target price (versus a $30.95 close) at Morgan Stanley.

Friday’s top analyst upgrades and downgrades were in Alibaba, Altria, Autodesk, Hormel, HP, Netflix, Tandem Diabetes, Turtle Beach and many more.